Related references
Note: Only part of the references are listed.Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
Hang-Long Li et al.
CARDIOVASCULAR DIABETOLOGY (2021)
SGLT2 inhibitors in cardiovascular medicine
Fahimeh Varzideh et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure
Hideo Nambu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials
Jiali Liu et al.
DIABETES OBESITY & METABOLISM (2020)
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
Angelo Maria Patti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Metformin May Contribute to Inter-individual Variability for Glycemic Responses to Exercise
Steven K. Malin et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney Disease
Tamara Y. Milder et al.
DRUG SAFETY (2020)
The combination of exercise training and sodium-glucose cotransporter-2 inhibition improves glucose tolerance and exercise capacity in a rodent model of type 2 diabetes
Melissa A. Linden et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
Influence of Sodium Glucose Cotransporter 2 Inhibition on Physiological Adaptation to Endurance Exercise Training
Alissa A. Newman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Effects of SGLT2 inhibitors on cardiovascular outcomes and mortality in type 2 diabetes A meta-analysis
Cai-Yan Zou et al.
MEDICINE (2019)
Exercise training and metformin, but not exercise training alone, decreases insulin production and increases insulin clearance in adults with prediabetes
Richard Viskochil et al.
JOURNAL OF APPLIED PHYSIOLOGY (2017)
Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients
Mohsen Mazidi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
Wataru Ogawa et al.
JOURNAL OF DIABETES INVESTIGATION (2016)
Positioning SGLT2 Inhibitors/Incretin-Based Therapies in the Treatment Algorithm
John P. H. Wilding et al.
DIABETES CARE (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS
Yehuda Handelsman et al.
ENDOCRINE PRACTICE (2016)
Impact of Metformin on Exercise-Induced Metabolic Adaptations to Lower Type 2 Diabetes Risk
Steven K. Malin et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2016)
Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition
Anne L. Peters et al.
DIABETES CARE (2015)
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients
Christian Cadeddu et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Metformin Modifies the Exercise Training Effects on Risk Factors for Cardiovascular Disease in Impaired Glucose Tolerant Adults
Steven K. Malin et al.
OBESITY (2013)
Independent and Combined Effects of Exercise Training and Metformin on Insulin Sensitivity in Individuals With Prediabetes
Steven K. Malin et al.
DIABETES CARE (2012)
Exercise-related hypoglycemia in diabetes mellitus
Lisa M. Younk et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2011)
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)
A Ramachandran et al.
DIABETOLOGIA (2006)